Agilent Technologies' ion exchange and size exclusion columns are designed for the analysis of bio-molecules including monoclonal antibodies, recombinant proteins, peptides, vaccine products and DNA/RNA.
According to the company, each column is individually tested with protein
samples to ensure column-to-column and batch-to-batch reproducibility. The
four new column families include:
Agilent Bio SEC-3 size exclusion columns, packed with a 3-µm particle and
offers high resolution and fast separation times, specifically for the
analysis of monoclonal antibody aggregates;
Agilent Bio SEC-5 size exclusion columns, packed with 5-m particles
coated with a neutral, hydrophilic coating, making the particle
extremely stable under harsh buffer conditions;
Agilent Bio MAb columns, featuring a weak cation exchange (WCX) resin specifically
designed for high-resolution separations of monoclonal antibody charge
Agilent Bio IEX columns, designed for high-resolution, high-recovery, and highly
efficient separations of proteins, peptides, oligonucleotides,and other bio-molecules.
Agilent Technologies is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. Agilent has two primary business segments: Bio-Analytical Measurement and Electronic Measurement. The company has 19,600 employees and serves customers in more than 110 countries. Agilent had revenue of $5.8B in fiscal year 2008.